Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017
Latest news articles
Added 2 years ago Drug news
Pivotal trial data on APPY1 Test for Appendicitis-Venaxis
Venaxis's pivotal APPY1 Test clinical trial data for acute Appendicitis were presented at the American College of Emergency Physicians Scientific...
Added 3 years ago Drug news
Venaxis files APPY1 test for Appendicitis with FDA - Venaxis
Venaxis has announced that it has filed a 510(k) premarket submission with the FDA for the APPY1 Test, a rapid,...
Added 3 years ago Drug news
Positive topline results for APPY1 Test for Appendicitis - Venaxis
Venaxis has announced positive top-line results from its pivotal US study of its CE Marked APPY1 Test, a rapid, multiple...
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Chronic Spontaneous Urticaria (CSU)
Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria
+ 3 more
Journal articles
Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
There has been greater interest in developing additional antimicrobial agents due to the increasing health care costs and resistance resulting from bacterial pathogens to currently available treatment options.
Added 5 months ago
Poor Sensitivity of a Modified Alvarado Score in Adults With Suspected Appendicitis
Study objective: A clinical decision rule that identifies patients at low risk for appendicitis may reduce the reliance on computed...
Added 4 years ago